{"id":"https://openalex.org/W4308378751","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0491","title":"491 Preclinical pharmacology modeling of HX009, a clinical stage first-in-class PD-1xCD47 BsAb, for anti-lymphoma applications","display_name":"491 Preclinical pharmacology modeling of HX009, a clinical stage first-in-class PD-1xCD47 BsAb, for anti-lymphoma applications","alternate_titles":[],"publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4308378751","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0491"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2022-sitc2022.0491","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0491","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0491","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A512.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"parent_works":[],"lineage":["https://openalex.org/W4308378751"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A512.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110445747","display_name":"Xiaoyu An","orcid":"https://orcid.org/0009-0004-5975-0727","observed_orcids":["https://orcid.org/0009-0004-5975-0727"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xiaoyu An","raw_affiliation_strings":["Crown Bioscience Inc, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crown Bioscience Inc, San Diego, CA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101654106","display_name":"Henry Li","orcid":"https://orcid.org/0000-0001-5587-968X","observed_orcids":["https://orcid.org/0000-0001-5587-968X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Henry Li","raw_affiliation_strings":["Hanx Pharmaceuticals, Inc., Wuhan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hanx Pharmaceuticals, Inc., Wuhan, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034660877","display_name":"Hang Ke","orcid":"https://orcid.org/0000-0001-7617-9332","observed_orcids":["https://orcid.org/0000-0001-7617-9332"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hang Ke","raw_affiliation_strings":["Hanx Pharmaceuticals, Inc., Wuhan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hanx Pharmaceuticals, Inc., Wuhan, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039179066","display_name":"Lingxin Xiong","orcid":"https://orcid.org/0000-0002-0160-7467","observed_orcids":["https://orcid.org/0000-0002-0160-7467"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lingxin Xiong","raw_affiliation_strings":["Crown Bioscience Inc, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crown Bioscience Inc, San Diego, CA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017295628","display_name":"Faming PanDongqing YeKechun Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Faming Zhang","raw_affiliation_strings":["Hanx Pharmaceuticals, Inc., Wuhan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hanx Pharmaceuticals, Inc., Wuhan, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056611512","display_name":"Mingfa Zang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mingfa Zang","raw_affiliation_strings":["Crown Bioscience Inc, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crown Bioscience Inc, San Diego, CA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Xiaolong Tu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xiaolong Tu","raw_affiliation_strings":["Crown Bioscience Inc, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crown Bioscience Inc, San Diego, CA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100426854","display_name":"Jingjing Wang","orcid":"https://orcid.org/0000-0001-9030-6377","observed_orcids":["https://orcid.org/0000-0001-9030-6377"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jingjing Wang","raw_affiliation_strings":["Crown Bioscience Inc, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crown Bioscience Inc, San Diego, CA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090007669","display_name":"Demi Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Demi Liu","raw_affiliation_strings":["Crown Bioscience Inc, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crown Bioscience Inc, San Diego, CA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Cen Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cen Chen","raw_affiliation_strings":["Crown Bioscience Inc, San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crown Bioscience Inc, San Diego, CA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003931681","display_name":"Cunxiang Ju","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157773","display_name":"Shanghai Model Organisms (China)","ror":"https://ror.org/057c2xb31","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210157773"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cunxiang Ju","raw_affiliation_strings":["Shanghai Model Organisms Center, Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai Model Organisms Center, Inc., Shanghai, China","institution_ids":["https://openalex.org/I4210157773"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103462952","display_name":"Xianfei He","orcid":"https://orcid.org/0009-0003-9401-8040","observed_orcids":["https://orcid.org/0009-0003-9401-8040"]},"institutions":[{"id":"https://openalex.org/I4210157773","display_name":"Shanghai Model Organisms (China)","ror":"https://ror.org/057c2xb31","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210157773"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xianfei He","raw_affiliation_strings":["Shanghai Model Organisms Center, Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai Model Organisms Center, Inc., Shanghai, China","institution_ids":["https://openalex.org/I4210157773"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100433814","display_name":"Lei Zhang","orcid":"https://orcid.org/0000-0001-6302-8383","observed_orcids":["https://orcid.org/0000-0001-6302-8383"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lei Zhang","raw_affiliation_strings":["Hanx Pharmaceuticals, Inc., Wuhan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hanx Pharmaceuticals, Inc., Wuhan, China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A512","last_page":"A512"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12672","display_name":"Phagocytosis and Immune Regulation","score":0.3962000012397766,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12672","display_name":"Phagocytosis and Immune Regulation","score":0.3962000012397766,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.2443999946117401,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.1704999953508377,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd47","display_name":"CD47","score":0.6359999775886536},{"id":"https://openalex.org/keywords/sirpalpha","display_name":"SIRP\u03b1","score":0.8299999833106995},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7139999866485596},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9179999828338623},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.7440000176429749},{"id":"https://openalex.org/keywords/t-cell-lymphoma","display_name":"T-cell lymphoma","score":0.7730000019073486},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.7879999876022339},{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.5870000123977661},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6610000133514404},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.781000018119812},{"id":"https://openalex.org/keywords/preclinical-pharmacology","display_name":"preclinical pharmacology","score":0.656000018119812}],"concepts":[{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.727796733379364},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6188746690750122},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48836418986320496},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.44539007544517517},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3827572464942932},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35764944553375244}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2022-sitc2022.0491","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0491","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0491","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A512.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2022-sitc2022.0491","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0491","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0491","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A512.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308378751.pdf","grobid_xml":"https://content.openalex.org/works/W4308378751.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362521942","https://openalex.org/W4380029378","https://openalex.org/W4362541093","https://openalex.org/W4404393596","https://openalex.org/W4405041067","https://openalex.org/W4308379195","https://openalex.org/W4282966756","https://openalex.org/W4282972041","https://openalex.org/W4388047690","https://openalex.org/W3212518782"],"abstract_inverted_index":{"Background":[0],"The":[1,279],"important":[2,62],"immune":[3,94],"checkpoint":[4],"inhibitors":[5],"(ICIs),":[6],"e.g.":[7,64],"PD1/PD-L1":[8],"and":[9,28,46,91,106,128,159,188,215,253,384],"CD47/SIRP\u03b1":[10],"blockers,":[11],"have":[12],"yet":[13],"to":[14,51,71,136,225,237,242,265,270,331],"be":[15,72,112],"successful":[16],"for":[17,44,370],"the":[18,41,85,108,137,156,233,238,266,271,277,287,308,346,355],"majority":[19],"of":[20,139,151,273,289,311,322,343,358],"non-Hodgkin\u2019s":[21],"lymphoma":[22,45,173,185,193,251,325],"(NHL),":[23],"albeit":[24],"efficacious":[25],"in":[26,34,40,152,166,220,232,276,329,376],"NK/T-cell":[27],"Hodgkin9s":[29],"lymphoma,":[30,66,380],"as":[31,33,56,58,228,353,361],"well":[32,57,354],"many":[35],"solid":[36],"tumors.":[37],"CD47":[38,147,267,302],"targeting":[39,87,124,268,310,350,360],"clinic,":[42],"predominantly":[43],"AML":[47],"remains":[48],"challenging":[49],"due":[50,236,269],"reported":[52],"toxicities":[53],"(e.g.":[54],"anemia/thrombocytopenia)":[55],"insufficient":[59],"efficacy.":[60],"Many":[61],"lymphomas,":[63],"T-cell":[65,274],"relapsed/refractory":[67,379],"DLBCL":[68],"etc.,":[69],"remain":[70],"unmet":[73],"medical":[74],"needs,":[75],"warranting":[76],"new":[77],"treatment":[78],"options,":[79],"particularly":[80],"immunotherapies.":[81],"We":[82],"hypothesized":[83],"that":[84,107,294],"dual":[86,309,359],"both":[88,295,312,349,382],"innate":[89],"(CD47)":[90],"adoptive":[92],"(PD-1)":[93],"check":[95],"points":[96],"with":[97,145,222,286,378],"a":[98,119,132,320],"bi-specific":[99],"antibody":[100],"(BsAb)":[101],"can":[102,111],"significantly":[103],"enhance":[104],"efficacy,":[105],"hematological":[109,230],"toxicity":[110,231],"minimized":[113],"through":[114],"specific":[115],"engineering.":[116],"Methods":[117],"HX009,":[118,260,344],"2x2":[120],"symmetric":[121],"BsAb":[122,373],"molecule":[123],"PD1/CD47,":[125],"was":[126,202,262],"designed":[127],"constructed":[129],"by":[130,165,204,259,313],"grafting":[131],"low":[133],"affinity":[134,241],"SIRP\u03b1":[135],"3\u2019":[138],"Fc":[140],"HX008":[141],"(anti-PD1":[142],"IgG1-Mab)":[143],"frame":[144],"weakened":[146],"binding.":[148],"A":[149,366],"series":[150],"vitro":[153],"characterizations":[154],"on":[155],"target":[157,211],"binding":[158,224],"functional":[160],"blocking":[161,214],"were":[162,218,327],"performed,":[163],"followed":[164],"vivo":[167],"pharmacology":[168],"modeling":[169,247],"using":[170,248],"several":[171],"preclinical":[172,340],"models":[174],"(10mg/kg,":[175],"twice":[176],"weekly,":[177],"i.p.),":[178],"including":[179,381],"subcutaneous":[180],"xenograft":[181,246],"(Karpas-299-T/Raji-B":[182],"lymphoma),":[183],"patient-derived":[184],"xenografts":[186],"(PDXs),":[187],"humanized":[189,280],"mouse":[190,282],"syngeneic":[191,281],"B-cell":[192],"A20":[194,284],"(HuGEMMTM":[195],"PD1Xcd47)":[196],".":[197],"Tumor":[198],"growth":[199],"inhibition":[200],"(TGI)":[201],"calculated":[203],"measuring":[205],"tumor":[206],"volume":[207],"biweekly.":[208],"Results":[209],"HX009":[210,314,337],"binding,":[212],"ligand":[213],"biological":[216],"effects":[217],"confirmed":[219,239],"vitro,":[221],"little":[223,229],"RBCs":[226],"along":[227],"NHP":[234],"studies":[235],"reduced":[240],"CD47.":[243],"All":[244],"tested":[245,328],"T-/B-":[249],"cell":[250,386],"CDXs":[252],"PDXs":[254,326],"revealed":[255,293],"strong":[256,339],"anti-lymphoma":[257,341],"activity":[258,342,357],"which":[261],"solely":[263],"attributed":[264],"lack":[272],"immunity":[275],"xenografts.":[278],"B-lymphoma":[283],"model":[285],"presence":[288],"competent":[290],"autologous":[291],"immune-system":[292],"single":[296],"targeting,":[297],"either":[298],"PD1":[299],"(HX008)":[300],"or":[301],"(SIRP\u03b1),":[303],"had":[304],"anti-tumor":[305,317],"activity,":[306],"while":[307],"caused":[315],"synergistic":[316],"activity.":[318],"Finally,":[319],"panel":[321],"fully":[323],"annotated":[324],"order":[330],"discover":[332],"potential":[333],"predicative":[334],"biomarkers.":[335],"Conclusions":[336],"demonstrated":[338],"confirming":[345],"contributions":[347],"from":[348],"MOAs":[351],"(CD47/PD1),":[352],"superior":[356],"designed,":[362],"validating":[363],"our":[364],"hypothesis.":[365],"Phase":[367],"I/II":[368],"study":[369],"this":[371],"first-in-class":[372],"is":[374],"ongoing":[375],"patients":[377],"B":[383],"T":[385],"subtypes":[387],"(ClinicalTrials.gov":[388],"Identifier:":[389],"NCT05189093).":[390]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4308378751","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-11-11T00:00:00"}
